Cargando…

Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia

BACKGROUND: To elucidate the genes involved in the neoplastic transformation of B cells, global gene expression profiles were generated using Affymetrix U74Av2 microarrays, containing 12,488 genes, for four different groups of mouse B-cell lymphomas and six subtypes of pristane-induced mouse plasma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Eun Sung, Shaughnessy, John D, Gupta, Shalu, Wang, Hongyang, Lee, Ju-Seog, Woo, Hyun Goo, Zhan, Fenghuang, Owens, James D, Potter, Michael, Janz, Siegfried, Mushinski, J Frederic
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040348/ https://www.ncbi.nlm.nih.gov/pubmed/17764563 http://dx.doi.org/10.1186/1471-2164-8-302

Ejemplares similares

Heterologous Tissue Culture Expression Signature Predicts Human Breast Cancer Prognosis
por: Park, Eun Sung, et al.
Publicado: (2007)

Distribution of the c‐MYC gene product in colorectal neoplasia
por: Baker, Ann‐Marie, et al.
Publicado: (2016)

AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements
por: Kovalchuk, Alexander L., et al.
Publicado: (2007)

Histological staining methods preparatory to laser capture microdissection significantly affect the integrity of the cellular RNA
por: Wang, Hongyang, et al.
Publicado: (2006)

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
por: Franqui-Machin, Reinaldo, et al.
Publicado: (2015)

Germline Risk Contribution to Genomic Instability in Multiple Myeloma
por: Janz, Siegfried, et al.
Publicado: (2019)

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2018)

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2019)

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
por: Yang, Ye, et al.
Publicado: (2014)

EVIDENCE FOR THE LINKAGE OF THE IGC(H) LOCUS TO A GENE CONTROLLING THE IDIOTYPIC SPECIFICITY OF ANTI-p-AZOPHENYLARSONATE ANTIBODIES IN STRAIN A MICE
por: Pawlak, Laura L., et al.
Publicado: (1973)

A gene signature can predict risk of MGUS progressing to multiple myeloma
por: Sun, Fumou, et al.
Publicado: (2023)

SHP2 Is Required for BCR-ABL1-Induced Hematologic Neoplasia
por: Gu, Shengqing, et al.
Publicado: (2017)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies
por: Liefwalker, Daniel F., et al.
Publicado: (2021)

The ABL-MYC axis controls WIPI1-enhanced autophagy in lifespan extension
por: Sporbeck, Katharina, et al.
Publicado: (2023)

Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
por: Kortlever, Roderik M., et al.
Publicado: (2017)

WDR26 and MTF2 are therapeutic targets in multiple myeloma
por: Sun, Fumou, et al.
Publicado: (2021)

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
por: Forshell, Linus Plym, et al.
Publicado: (2011)

Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma
por: Jain, Aditi, et al.
Publicado: (2017)

Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice
por: Kadariya, Yuwaraj, et al.
Publicado: (2013)

ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1
por: Mayro, Benjamin, et al.
Publicado: (2023)

Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia
por: Wang, Huabo, et al.
Publicado: (2022)

Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma
por: Pisano, Michael, et al.
Publicado: (2021)

IL6Myc mouse is an immunocompetent model for the development of aggressive multiple myeloma
por: Pisano, Michael D., et al.
Publicado: (2023)

Detection of MYC gene amplification in malignant lymphomas.
por: Park, C. K., et al.
Publicado: (1998)

MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance
por: Marengo, Barbara, et al.
Publicado: (2019)

Characterization of ARF-BP1/HUWE1 Interactions with CTCF, MYC, ARF and p53 in MYC-Driven B Cell Neoplasms
por: Qi, Chen-Feng, et al.
Publicado: (2012)

Gene Array Studies in Renal Neoplasia
por: Higgins, John P.T.
Publicado: (2006)

Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients
por: Roy Choudhury, Samrat, et al.
Publicado: (2021)

Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
por: Gu, Chunyan, et al.
Publicado: (2018)

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)

KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice
por: Sin, Sang-Hoon, et al.
Publicado: (2015)

Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.
por: Hendy-Ibbs, P., et al.
Publicado: (1987)

Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia
por: Govindarajan, Baskaran, et al.
Publicado: (2012)

MYCL1 Amplification and Expression of L-Myc and c-Myc in Surgically Resected Small-Cell Lung Carcinoma
por: Qin, Jing, et al.
Publicado: (2021)

Homeobox genes in mammary gland development and neoplasia
por: Lewis, Michael T
Publicado: (2000)

Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia
por: Chen, Shaomin, et al.
Publicado: (2012)

Loss of retinoblastoma gene and amplification of N-myc gene in retinoblastoma.
por: Choi, S. W., et al.
Publicado: (1993)

GENETICS OF A NEW IgV(H) (T15 IDIOTYPE) MARKER IN THE MOUSE REGULATING NATURAL ANTIBODY TO PHOSPHORYLCHOLINE
por: Lieberman, R., et al.
Publicado: (1974)

CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms
por: Han, Seong-Su, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ujf8e870r88oqf9i8imgfnu5cq